NDR for Institutional Investors (Introducing Subsidiary Verismo Therapeutics)
-
IR event: NDR for domestic and foreign institutional investors in Seoul, May 6-8, 2026
-
Purpose: Enhance investor understanding and corporate value
-
Main content: Business explanation and Q&A on subsidiary Verismo Therapeutics
KOSDAQ Filing Information
-
Filing: Holding of Investor Relations Conference (IR)
-
Company: HLB innoVation (024850)
-
Submission: HLB innoVation Co.,Ltd.
-
Receipt: 04-30-2026
-
Under KRX KOSDAQ Market Division